Home› Tender for Procurement Of Medical And Pharmaceutical Products Including Amivantamab And Vorhyaluronidase Alfa. Amivantamab (genetical Recombination), Vorhyaluronidase Alfa (genetical Recombination)(10ml/vial), 120 Vials, Japan

National University Corporation has issued a public tender related to Procurement Of Medical And Pharmaceutical Products Including Amivantamab And Vorhyaluronidase Alfa. Amivantamab (genetical Recombination), Vorhyaluronidase Alfa (genetical Recombination)(10ml/vial), 120 Vials in Japan. Interested bidders can submit applications before 29 Jul 2026.

Tender Notice

Tender Notice
Tender TI Ref No
533798335
Tender Date
08 Jun 2026
Tender Description
Tender for Procurement Of Medical And Pharmaceutical Products Including Amivantamab And Vorhyaluronidase Alfa. Amivantamab (genetical Recombination), Vorhyaluronidase Alfa (genetical Recombination)(10ml/vial), 120 Vials
Tender Deadline
⏰ 29 Jul 2026 Closing soon
Tender Project Location
Japan
Tender Sector
Healthcare & Medical - Medical Tenders
Tender CPV
Injectable solutions Tenders
Tender Document Type
Tender Notice
Tender Organization Name
🔒 Members only Click for more details
Unlock Full Details — Register Free
Start with receiving Free Data Samples related to your Products and Services
✓
Live Tender Updates from worldwide
✓
Access to original Tender Documents
✓
Information on Upcoming Projects & Contract Awards
✓
Bid Assistance Services
✓
Competitor Analysis & Industry Trends
✓
Daily Custom Email Alerts by Sector & Country

Similar Tenders

View All Healthcare & Medical - Medical Tenders Tenders ->

Register to View Tenders

Start Your Business Journey. Register now for 3 days Free Sample Tenders & AI Website Demo.

Already have an account? Login here

By registering you agree to our Terms & Conditions and Privacy Policy.